Shilpa Shetty gets real in Limelight Lab Grown Diamonds' new ad
, India's fastest-scaling lab-grown diamond jewellery brand, has unveiled its new brand campaign 'Let's Get Real' a powerful call to reimagine luxury through the lens of innovation, ethics and
conscious consumption
. At the heart of this movement is actor, entrepreneur and wellness icon
Shilpa Shetty
, who joins the brand also as a strategic investor.
The campaign signifies a defining moment in the evolution of India's
luxury jewellery
landscape.
With 'Let's Get Real', Limelight takes a firm stance against outdated narratives and legacy perceptions, positioning itself as the torchbearer of new-age luxury in India.
'Limelight isn't just participating in the lab-grown diamond category, we're building it,' said Pooja Sheth Madhavan, founder and managing director, Limelight
Lab Grown Diamonds
. 'As a first mover, we carry the responsibility to lead the shift in how lab grown diamonds are perceived. With an aggressive roadmap to open 100 stores by 2026, we're scaling both reach and relevance. 'Let's Get Real' calls out traditional myths about luxury and offers a compelling promise of diamonds that shine boldly with a purpose. This campaign is more than marketing; it's a cultural reset.'
Shetty, as the brand ambassador, lends her voice and credibility to a campaign grounded in mindful luxury. Her entrepreneurial mindset, public commitment to conscious living and aspirational appeal make her a strategic fit and a firm believer of the movement.
'What drew me to Limelight was the honesty of their story,' said Shetty. 'Lab-grown diamonds are a smart and responsible choice. As someone who values authenticity and mindful choices, investing in Limelight felt natural. With 'Let's Get Real', you can wear something stunning yet meaningful without any compromise. That's the future of luxury, and I'm proud to help shape it.'
The campaign taps into a powerful consumer truth that the modern Indian woman is increasingly value-driven, informed, and conscious. With sustainability, innovation, and transparency rising as critical purchase factors, lab-grown diamonds are fast becoming the preferred choice for a new generation of luxury consumers.
''Let's Get Real' is not a cosmetic line, it's our core positioning,' said Rupali Shrivastava, chief marketing officer, Limelight Lab Grown Diamonds. 'Luxury today is about meaning, not legacy. Our integrated 360° campaign spans TV, digital, print, OOH, multiplex cinema, influencers, and in-store experiences. It's backed by deep consumer insight showing strong traction for labgrown diamonds among young, independent women across India. This is not meant to sit in lockers or wait for occasions. It's made to be worn every day, everywhere by women who want their diamonds to reflect their values and lifestyle. We are not just responding to this shift, we're driving it.'
With its vision and a brand ambassador who puts belief into action through investment, Limelight is redefining what it means to lead a category. 'Let's Get Real' is not just a campaign, it's a blueprint for the future of luxury in India, the press note shared with ETBrandEquity stated.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
17 minutes ago
- Hans India
AGPL achieves a significant feat by berthing deepest-drafted vessel
Visakhapatnam: Adani Gangavaram Port Limited (AGPL) achieved a landmark feat in Indian marine operations by successfully berthing the deepest-drafted vessel in its operational history. The vessel, carrying 177,121 metric tonnes (MT) of bauxite consigned by Vedanta Limited, arrived with an 18.2-mt draft—surpassing AGPL's previous record of 18.12-mt. After completing cargo operations with precision, the vessel sailed out, setting a new standard for the port's marine capabilities. The operational success is a demonstration of AGPL's ability to deliver high-volume, high-complexity cargo handling with world-class efficiency. Such deep-drafted handling requires robust marine infrastructure, advanced navigational capabilities and seamless coordination across port, pilotage and customer teams. Close collaboration with Vedanta Limited ensured optimal berthing, quick turnaround, and precise handling of the shipment. For industries dependent on large-scale raw material imports, these efficiencies directly translate to cost savings, smooth supply chains, and reduced environmental footprint per tonne handled. The milestone also underlines AGPL's commitment to supporting India's industrial growth. By accommodating larger vessels, AGPL enables customers to leverage economies of scale, boosting India's competitiveness in global trade. This latest record reinforces AGPL's status as a preferred maritime gateway for the east coast, capable of handling diverse cargoes from dry bulk to project cargo and containerised freight. Over the years, the port has invested in deep-water berths, mechanised cargo handling systems and advanced marine safety protocols, ensuring it can meet the demands of both current and future trade flows.
Mint
17 minutes ago
- Mint
Nifty 50, Sensex today: What to expect from Indian stock market in trade on August 13 after Wall Street rally
The Indian stock market benchmark indices, Sensex and Nifty 50, are likely to open higher on Wednesday, tracking positive cues from global markets. The trends on Gift Nifty also indicate a strong start for the Indian benchmark index. The Gift Nifty was trading around 24,619 level, a premium of nearly 64 points from the Nifty futures' previous close. On Tuesday, the equity market resumed its downward trajectory and ended lower. The Sensex declined 368.49 points, or 0.46%, to close at 80,235.59, while the Nifty 50 settled 97.65 points, or 0.40%, lower at 24,487.40. Here's what to expect from Sensex, Nifty 50 and Bank Nifty today: Sensex faced resistance near 81,000 and reversed sharply. 'We are of the view that the current market texture is non-directional; hence, level-based trading would be the ideal strategy for day traders. On the higher side, 80,500 would act as an immediate resistance zone. Above this level, Sensex could bounce back up to 81,000 - 81,200. On the lower side, below 80,000, selling pressure is likely to accelerate. Below this level, Sensex could retest the levels of 79,800 - 79,500,' said Shrikant Chouhan, Head Equity Research, Kotak Securities. On the derivatives front, the highest Call Open Interest (OI) for Nifty is at the 24,500 strike, followed by 24,600 and 24,700, indicating these levels could act as immediate resistance. On the Put side, the highest OI is also at the 24,500 strike, followed by 24,400, highlighting strong support zones. This OI setup suggests that the 24,400–24,600 range will be crucial for Nifty's near-term movement, and a breakout on either side could dictate the next directional trend, said Hardik Matalia, Derivative Analyst - Research at Choice Equity Broking. Nifty 50 formed an inverted hammer candle on the daily chart, indicating selling pressure at higher levels. 'A small red candle was formed on the daily chart with a long upper shadow. Technically, this market action indicates a lack of strong upside momentum to surpass the overhead hurdle. The bulls may hold the ground as long as the base of 24,300 is protected,' said Nagaraj Shetti, Senior Technical Research Analyst at HDFC Securities. According to him, the short term uptrend that resumed after a sharp upmove of Monday remains intact and expects buying to emerge from near the supports of 24,300 - 24,400 levels in the coming sessions. Hence, one may expect Nifty 50 to retest the crucial hurdle of around 24,700 in the short term. Nilesh Jain, Head – Technical and Derivatives Research Analyst (Equity Research), Centrum Broking Ltd. said that the Nifty 50 index formed a bearish candle with a long upper shadow on the daily chart, highlighting selling pressure at higher zones. 'For any meaningful pullback, it is crucial for the Nifty 50 index to reclaim 24,500, which could then open the door for a retest of 24,700. Overall, we expect the Nifty to remain range-bound between 24,330 (support) and 24,700 (resistance),' Jain said. VLA Ambala, Co-Founder of Stock Market Today advises traders to continue with the sell-on-rise strategy, and expects Nifty 50 to find support between 24,410, 24,305, and 24,240 and meet resistance near 24,580, 24,650, and 24,730 in today's trading session. Bank Nifty index declined 467.05 points, or 0.84%, to close at 55,043.70 on Tuesday, forming an Inside Bar candlestick pattern on the daily chart, reflecting indecision in the market. 'Bank Nifty formed a bearish candle in the daily chart and remains positioned below the 50-SMA, 20-SMA, and 9-EMA, indicating sustained short-term weakness. The 100-SMA is placed around the 55,000 mark, and a decisive slip below this level could accelerate the downside momentum and invite further selling pressure,' said Om Mehra, Technical Research Analyst, SAMCO Securities. On the hourly chart, the Bank Nifty index maintains a clear pattern of lower lows and lower highs. The broader support levels are now layered at 54,700, followed by 54,450, which could act as the next cushion if the weakness persists, he added. 'On the upside, until the Bank Nifty index closes back above 55,650, rallies are likely to remain short-lived, with any recovery attempts expected to face firm resistance near this pivotal zone,' Mehra said. Hrishikesh Yedve, AVP Technical and Derivative Research, Asit C. Mehta Investment Interrmediates Ltd. highlighted that on the downside, the 100-DEMA, placed near 54,950, is acting as strong support. 'As long as Bank Nifty holds above this level, a short-term pullback remains possible. On the upside, the 34- DEMA hurdle near 56,050 will act as major resistance. Break below 54,950 could open the doors for 54,500 levels,' Yedve said. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Economic Times
17 minutes ago
- Economic Times
We are holding 14-15% in cash in this slightly bearish undertone market: Siddharth Vora
Siddharth Vora, Head - Investment Strategy & Fund Manager, PL Asset Management, says the Indian market is seeing strong domestic liquidity. Mutual fund inflows and SIP are at record highs. This shows positive investor sentiment. Globally, FIIs are selling due to tariff concerns. The market is range-bound with rallies followed by profit booking. Corrections are followed by value buying. Geopolitical de-escalation and a US trade deal could trigger an upside for India. ADVERTISEMENT To start with, we have to give this recognition to the Indian markets. No matter how many global uncertainties we see, no matter how many accidents and warlike scenarios we see, Indian markets have remained resilient. At least in the longer-term picture, the undertone in the longer term for the market remains positive. How do you see the texture of domestic markets considering all of the global uncertainties and the developments going around these days? Siddharth Vora: So, the most encouraging part about Indian markets currently is the domestic liquidity. Again, just yesterday or day before yesterday the print numbers were out for mutual fund inflows and SIP, on a monthly basis we are making record highs. So, the domestic liquidity is a very strong indicator for how the investors in India are thinking about Indian markets. Of course, globally things do not appear to be that great. FIIs are selling. The whole tariff surprise has been very negative for India. The outcomes and structure are also not going in the right direction. I think this is negotiation tactics and eventually wisdom will prevail and things will get better from here. Disinflation is going to be the big theme for India: Sonal Varma, Nomura Right now, it looks like short-term rally, then profit booking, again relief rally, then again correction. So, it is a very range-bound market where after every rally you will see some profit booking and after every correction you will see some value buying. So, the markets are likely to be range bound. Fresh triggers from here could be geopolitical de-escalation and the trade deal with the US. This could provide the missing triggers that India needs for a meaningful upside from here. The data point that came out shows a lot of resilience as far as the domestic investors are concerned. We have remained resilient on geopolitical tensions, whether it is in the form of tariff or warlike situation, the strength can be seen with DII buying as well as the retail investors with the AMFI data that came out. The consumption basket is likely to do better because we are going to look at more domestic-facing sectors whether it is consumption, or industrials. You have a lot of industrials in your portfolio. Are these names going to do better? Siddharth Vora: The domestic macros, while resilient and healthy, are less likely to be a trigger to take the markets ahead. They are more likely to be the base for the market. They are more likely to provide support and resilience to the market rather than take it ahead. We all know that in India, inflation is under control. Growth is on track. The interest rate cycle has turned favourable and domestic liquidity is strong. So, pretty much all four engines are supporting a stable domestic economy and stable domestic markets. Despite all of this on a one-month and 12-month basis, India has been the worst performing market in the world. Clearly, our global positioning is getting eroded with the tariff situation. China is getting a much more favourable treatment and India is getting a much more adverse treatment and this can be seen in the way foreign flows are evolving. In terms of sectors, yes, domestic-focused plays across industries, not necessarily consumer alone, but across industries are likely to do better. So, we have meaningfully reduced our allocation in financials. We were at 42% last month. We are down to roughly 30%. We have exited private banks a month, month-and-a-half back. Materials, whether it is cement and metals and mining, we have meaningfully scaled up to roughly 18-20% of the portfolio. In fact, we have been trimming industrials a bit down from 10% to 8%. Healthcare is the new sector, where we have started gradually building up allocations. ADVERTISEMENT We had no allocations up till last month and over the last 20-30 days, we have increased the allocations to roughly 6%. And the other major exit has been IT. We are down to roughly 1-2% from 12% last month. So, quite a few changes in the portfolio. We also hold a cash reserve of roughly 14-15% in this choppy volatile and slightly bearish undertone market. Unlock 500+ Stock Recos on App While we compare the benchmarks with the broader markets, I want to understand your investment strategy. If an investor has capital and is willing to park that capital, what asset classes should one eye because we are talking largely about equity markets but at the same time, when we talk about investments, should we consider all the asset classes? Siddharth Vora: That is right. A multi-asset allocation strategy is pretty much an all-weather strategy where based on your risk profile, strategically you are diversifying across equities, debt, gold, sometimes silver and real estate as well. That is a great strategy for an all-weather low-risk moderate return investor. But coming to pure equity investors who want to not diversify those risks and therefore not diversify those returns as well, a pure equity approach is likely suited. Within a pure equity approach, heavier focus to large and midcap should be considered at this point given smallcap valuations are still very expensive compared to largecaps. ADVERTISEMENT Midcap valuations are also not cheap, but they are somewhere in the middle. So, a larger cap bias should help build resilience in the portfolio and when you talk about style, being a quant fund manager, it is not that my investment style or particular style preference matters. We rely on our quantitative models to decide which investment style to use at which part of the market cycle. Our models also decide which sectors to over allocate and under allocate to. Our models also decide which market cap group will get how much weight. So, from that perspective, over the last two years, we have seen two-three major shifts in investing style. Between June 23 to June 24, we saw value and momentum driven style approaches in our portfolio that did very well to capture the alpha on the upside because market conditions were healthy. ADVERTISEMENT Post that, so from July 24 to December 24 we saw quality and low volatility tilt in our portfolio that helped us maintain alpha, protect capital draw downs, and sort of balance the portfolio in a sideways market. Post that, in the last six months, factor spreads have narrowed significantly which means all the factors are underperforming to a similar extent. There is no clear factor or style trend in India at the moment and therefore, it hints that a balanced multi-factor profile is suited in the current market environment because obviously there is a clear lack of momentum in markets, in sectors, and in factors. So, in such choppy market conditions, it is better to stay diversified across investment styles. It is better to stay diversified across market cap and not take a very polarised style or sector call in a current setup. Diversification and balance is more important than trying to get the one style right in this market environment because there is a lot of uncertainty around global cues. It is not easy to take a style call at this point of time. ADVERTISEMENT What is your view on the pharmaceutical sector? When I say pharma sector, it is just not one sector anymore but it has been diversified into so many spaces and subsegments like healthcare, diagnostic, CDMO, and laboratory space. Trump is saying that pharma tariffs could eventually reach up to 250%. One thing is sure that uncertainty around tariffs is disincentive at least for the pharma space and any tariff for pharma will definitely hit India because 40% exports go to the US. What is your take on that? Siddharth Vora: I would call it the healthcare sector when you talk about hospitals, pharmaceuticals, CDMO, diagnostics – the whole pack is rather classified under the healthcare segment. Within healthcare, you can have more domestic focused players and more globally exposed players as well. Our strategy is to strike a balance between globally focused and domestically focused plays simply because the kind of tariffs Trump has in mind, they are less likely to play out in the real world because it is not easy to relocate supply chains overnight with such tariffs and India being a critical supplier of so many pharmaceutical key products, I do not think it is easy for them to be replaced overnight and it is not even good for the US economy and the US consumer for such a tariff structure to play out for the critical healthcare and pharmaceutical sector. That risk is something we should take right now when we go long healthcare against the anticipated tariffs to know that eventually wisdom will prevail and things will go back to normal. So, we are going to take a slight risk there and balance our positions between pure play domestic focused healthcare companies and a bit of globally focused or globally exposed healthcare companies who also have a larger part of their revenues coming from non-US regions, so that could be a decent strategy in terms of approaching healthcare. (You can now subscribe to our ETMarkets WhatsApp channel)
